Kaplan Fox Alerts Flotek Industries, Inc. (NYSE: FTK) Investors Who Suffered Losses to a Securities Class Action - Deadline is October 26, 2026

Flotek shares fell $7.17, or 20%, to $28.66 on August 17, 2026, after Wolfpack Research alleged that the company’s $400 million PREPA contract—about 57% of its backlog—had been canceled. A class action lawsuit alleges Flotek’s statements about its business and prospects were misleading because of risks that revenue from the 10-year, 400 MW project would not be realized. The lead-plaintiff deadline is October 26, 2026.

Analysis

The incremental signal is not the filing itself, but whether the PREPA award was ever executable. The cancellation claim cited in the complaint remains an allegation attributed to a short-seller report; this notice supplies no independent confirmation. If the project is impaired, the key risk is backlog quality and customer/project concentration, not the lawsuit’s eventual damages. Conversely, a verified active contract with credible consortium financing and procurement milestones would challenge the bearish thesis.

Near term, the October 26 lead-plaintiff deadline is procedural, not a merits catalyst. The larger 1–3 month catalysts are company, PREPA, or consortium disclosures and any evidence that changes expected contract conversion. Over 6–18 months, repeated delays or removal of the award could weigh on growth expectations; litigation discovery may also surface facts, but timing and outcome are uncertain. The reported 57% backlog exposure should be treated as an allegation until reconciled with company filings and the backlog definition.

Contrarian view: the initial sharp repricing may already reflect much of the cancellation risk, while a lawsuit headline alone does not establish new economic damage. But the uncertainty is asymmetric if the award was important to expected growth. Avoid treating either the award or its cancellation as established without primary-source confirmation.

Key Decisions for Investors

• Do not initiate a fresh outright short solely on this notice: the alleged contract cancellation was already public in August, and the filing adds allegations rather than verified operating facts. Reassess only if primary-source evidence confirms the award is terminated or materially delayed.
• For existing FTK exposure, cap position size or use a defined-risk hedge while the contract status is unresolved; avoid unhedged exposure sized on the assumption that the announced award converts to revenue.
• Set an alert for company filings and PREPA/consortium updates. Verify contract execution, financing, permits, milestones, termination rights, and how the company defines and reports backlog before changing the fundamental view.
• Falsify the bearish project-risk thesis if credible counterparties and funding are confirmed and the project advances through documented milestones; strengthen it if the company removes the award from backlog, revises guidance, or confirms cancellation.